Stocks · Healthcare · Medical - Instruments & Supplies
ResMed Inc. RMD
$218.89 -1.02% Close, Oct 2, 2026 · NYSE · Market cap $31.75B
High qualityInexpensive vs sectorLow risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 21.0× trailing earnings, lower than 95% of the company's own readings over the past five years.
- Earnings beat analyst estimates in each of the last 5 quarters (average surprise over the last four: +2.1%).
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 48%
- EPS growth (TTM, YoY)Top 50%
- FCF growth (TTM, YoY)Top 21%
- Revenue growth, 3-year CAGRBottom 50%
- Revenue growth accelerationBottom 48%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 6%
- Gross marginBottom 46%
- Operating marginTop 5%
- Cash conversion (OCF / net income)Top 30%
- Accruals (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Top 28%
- Interest coverTop 5%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 11%
- Free-cash-flow yieldTop 9%
- EBITDA / enterprise valueTop 17%
- Sales / enterprise valueBottom 45%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 27%
- 6-month returnBottom 41%
- 1-year return vs S&P 500Bottom 29%
- Distance from 52-week highTop 37%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 47%
- Consecutive EPS beatsTop 15%
- Share of analysts rating BuyBottom 8%
- Upside to consensus price targetBottom 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 11%
- Maximum drawdown, 3 yearsTop 12%
- Beta vs S&P 500 (lower is better)Top 23%
- Net debt / EBITDA (lower is better)Top 28%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 10.3% | 9.9% | ↓ |
| EPS growth (YoY) | 16.0% | 9.4% | ↓ |
| Gross margin | 59.4% | 61.2% | ↑ |
| Operating margin | 32.7% | 33.5% | ↑ |
| FCF margin | 32.2% | 51.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 9.9% | 10.3% | ↓ | Top 48% |
| EPS growth (TTM, YoY) | 9.4% | 16.0% | ↓ | Top 50% |
| Gross margin | 61.2% | 59.4% | ↑ | Bottom 46% |
| Operating margin | 33.5% | 32.7% | ↑ | Top 5% |
| Net margin | 26.9% | 27.2% | ↓ | — |
| Free-cash-flow margin | 51.1% | 32.2% | ↑ | — |
| Return on invested capital | 19.1% | — | Top 6% | |
| Revenue growth, 3-year CAGR | 10.2% | — | Bottom 50% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.07×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -18.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.30×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 65.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.93%
- Net buyback yield (TTM)
- 3.40%
- Shareholder yield
- 5.33%
- Share count change, 1 year
- -1.4%
- Share count change, 3-year CAGR
- -0.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 5
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +2.1%
- Average 2-day reaction, last 8
- +0.1%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $242.70
- Target vs current price
- +10.9%
- Analysts with a rating
- 35
- Share rating Buy or Strong Buy
- 40%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +2.1% | -0.4% | +0.9% | +3.1% | — |
| Apr 30, 2026 | +2.1% | +0.9% | -1.1% | -4.0% | -4.2% |
| Jan 29, 2026 | +2.6% | -0.0% | +2.1% | -0.3% | -14.7% |
| Oct 30, 2025 | +1.6% | -0.5% | -3.3% | +0.6% | +0.7% |
| Jul 31, 2025 | +3.7% | -2.0% | +1.1% | +1.6% | -4.4% |
| Apr 23, 2025 | -0.4% | +0.1% | +11.1% | +15.9% | +20.5% |
| Jan 30, 2025 | +4.7% | +1.9% | -4.1% | -8.5% | -6.7% |
| Oct 24, 2024 | +7.8% | +0.7% | +2.4% | +1.7% | +4.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $2.95 | $2.89 | +2.1% | $1.46B |
| Apr 30, 2026 | $2.86 | $2.80 | +2.1% | $1.43B |
| Jan 29, 2026 | $2.81 | $2.74 | +2.6% | $1.42B |
| Oct 30, 2025 | $2.55 | $2.51 | +1.6% | $1.34B |
| Jul 31, 2025 | $2.55 | $2.46 | +3.7% | $1.35B |
| Apr 23, 2025 | $2.37 | $2.38 | -0.4% | $1.29B |
| Jan 30, 2025 | $2.43 | $2.32 | +4.7% | $1.28B |
| Oct 24, 2024 | $2.20 | $2.04 | +7.8% | $1.22B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 21.0× | 31.3× | 5th | Top 11% |
| P/E (forward) | 18.1× | — | — | — |
| EV / EBITDA | 14.5× | — | — | Top 17% |
| EV / Sales | 5.50× | — | — | Bottom 45% |
| Free-cash-flow yield | 9.10% | — | — | Top 9% |
| Earnings yield | 4.75% | — | — | Top 11% |
P/E over the past five years
Range 19.8× – 86.6× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -19.2%
- Earnings per share growth (TTM)
- +9.4%
- Change in P/E multiple
- -27.0%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +4.0%
- 200-day average slope (20 days)
- -1.2%
- Distance from 50-day average
- -2.0%
- Distance from 200-day average
- -3.0%
- RSI (14)
- 41.2
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 31.0%
- Volatility vs own 5-year history
- 56th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.64
- Correlation with S&P 500
- 0.37
- Current drawdown from 1-year high
- -22.7%
- Maximum drawdown, 3 years
- -37.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 8, 2021 | Oct 27, 2023 | -54.7% | 538 days | Not yet recovered |
| Jan 26, 2021 | Mar 8, 2021 | -19.3% | 28 days | 68 days (Jun 14, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $31.75B
- P/E (TTM)
- 21.0
- EPS, diluted (TTM)
- $10.40
- Revenue (TTM)
- $5.65B
- Dividend yield
- 1.12%
- 52-week range
- $180.27 – $284.87
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
| Gross profit | $2.02B | $2.36B | $2.66B | $3.05B | $3.46B |
| Operating income | $1.00B | $1.13B | $1.32B | $1.69B | $1.89B |
| Net income | $779.4M | $897.6M | $1.02B | $1.40B | $1.52B |
| EPS (diluted) | $5.30 | $6.09 | $6.92 | $9.51 | $10.40 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B | $1.46B |
| Net income | $311.4M | $344.6M | $365.0M | $379.7M | $348.5M | $392.6M | $398.7M | $383.4M |
| EPS (diluted) | $2.11 | $2.34 | $2.48 | $2.58 | $2.37 | $2.68 | $2.71 | $2.64 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $351.1M | $693.3M | $1.40B | $1.75B | $1.81B |
| Capital expenditure | -$156.0M | -$134.0M | -$114.9M | -$89.9M | -$156.3M |
| Free cash flow | $195.1M | $559.3M | $1.29B | $1.66B | $1.65B |
| Dividends paid | -$245.3M | -$258.3M | -$282.3M | -$310.9M | -$349.7M |
| Net share buybacks | $47.4M | $49.1M | -$96.9M | -$225.6M | -$625.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.47B
- Total assets
- $8.97B
- Total liabilities
- $2.38B
- Total debt
- $825.9M
- Net debt
- -$643.3M
- Shareholders’ equity
- $6.59B
As of Jun 30, 2026 (filed Aug 13, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 20, 2026 | $0.66 | Sep 24, 2026 |
| May 14, 2026 | $0.60 | Jun 18, 2026 |
| Feb 12, 2026 | $0.60 | Mar 19, 2026 |
| Nov 13, 2025 | $0.60 | Dec 18, 2025 |
| Aug 14, 2025 | $0.60 | Sep 18, 2025 |
| May 8, 2025 | $0.53 | Jun 12, 2025 |
| Feb 13, 2025 | $0.53 | Mar 20, 2025 |
| Nov 7, 2024 | $0.53 | Dec 12, 2024 |
Short interest
- Shares sold short
- 14,203,907
- Days to cover
- 11.74
- Change vs previous report
- +8.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 31, 2010
- 2-for-1
- Oct 3, 2005
- 2-for-1
- Apr 3, 2000
- 2-for-1
- Nov 17, 1998
- 2-for-1